Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 371

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Clinical Intestinal Transplantation: A Decade of Experience at a Single Center

Open access
Abu-Elmagd, Kareem, Reyes, Jorge, Bond, Geoffrey, Mazariegos, George, Wu, Tong, Murase, Noriko, Sindhi, Rakesh, Martin, Dolly, Colangelo, Joanne, Zak, Marsha, Janson, Douglas, Ezzelarab, Mohamed, Dvorchik, Igor, Parizhskaya, Maria, Deutsch, Melvin, Demetris, Anthony, Fung, John, Starzl, Thomas E.·2001·Annals of Surgery

Abstract

OBJECTIVE: To assess the long-term efficacy of intestinal transplantation under tacrolimus-based immunosuppression and the therapeutic benefit of newly developed adjunct immunosuppressants and management strategies. SUMMARY BACKGROUND DATA: With the advent of tacrolimus in 1990, transplantation of the intestine began to emerge as therapy for intestinal failure. However, a high risk of rejection, with the consequent need for acute and chronic high-dose immunosuppression, has inhibited its widespread application. METHODS: During an 11-year period, divided into two segments by a 1-year moratorium in 1994, 155 patients received 165 intestinal allografts under immunosuppression based on tacrolimus and prednisone: 65 intestine alone, 75 liver and intestine, and 25 multivisceral. For the transplantations since the moratorium (n = 99), an adjunct immunosuppressant (cyclophosphamide or daclizumab) was used for 74 transplantations, adjunct donor bone marrow was given in 39, and the intestine of 11 allografts was irradiated with a single dose of 750 cGy. RESULTS: The actuarial survival rate for the total population was 75% at 1 year, 54% at 5 years, and 42% at 10 years. Recipients of liver plus intestine had the best long-term prognosis and the lowest risk of graft loss from rejection (P =.001). Since 1994, survival rates have improved. Techniques for early detection of Epstein-Barr and cytomegaloviral infections, bone marrow augmentation, the adjunct use of the interleukin-2 antagonist daclizumab, and most recently allograft irradiation may have contributed to the better results. CONCLUSION: The survival rates after intestinal transplantation have cumulatively improved during the past decade. With the management strategies currently under evaluation, intestinal transplant procedures have the potential to become the standard of care for patients with end-stage intestinal failure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00000658-200109000-00014

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 371

Metadata

Authors
Abu-Elmagd, K., Reyes, J., Bond, G., Mazariegos, G., Wu, T., Murase, N., Sindhi, R., Martin, D., Colangelo, J., Zak, M., Janson, D., Ezzelarab, M., Dvorchik, I., Parizhskaya, M., Deutsch, M., Demetris, A., Fung, J., & Starzl, T. E.
Venue
Annals of Surgery
Published
2001-09
Volume
234
Issue
3
Pages
404-417
ISSN
0003-4932 (ISSN-L)
OpenAlex
W2012720158
Cited by
371
References
24
FWCI
34.47
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Intestinal Transplantation: A Decade of Experience at a Single Center. https://app.cochat.ai/papers/10.1097/00000658-200109000-00014
The paper
Abu-Elmagd, K., Reyes, J., Bond, G., Mazariegos, G., Wu, T., Murase, N., Sindhi, R., Martin, D., Colangelo, J., Zak, M., Janson, D., Ezzelarab, M., Dvorchik, I., Parizhskaya, M., Deutsch, M., Demetris, A., Fung, J., & Starzl, T. E. (2001). Clinical Intestinal Transplantation: A Decade of Experience at a Single Center. Annals of Surgery. https://doi.org/10.1097/00000658-200109000-00014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.